GLM3
MCID: GLM047
MIFTS: 32

Glioma Susceptibility 3 (GLM3)

Categories: Cancer diseases, Genetic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Glioma Susceptibility 3

MalaCards integrated aliases for Glioma Susceptibility 3:

Name: Glioma Susceptibility 3 57 29 6
Glioblastoma 3 57 29 13
Glm3 57 72
Glioma, Susceptibility, Type 3 39
Glioma 3 72

Characteristics:

OMIM®:

57 (Updated 05-Apr-2021)
Inheritance:
autosomal recessive


HPO:

31
glioma susceptibility 3:
Inheritance autosomal recessive inheritance


Classifications:



External Ids:

OMIM® 57 613029
OMIM Phenotypic Series 57 PS137800
MeSH 44 D005910
MedGen 41 C2751641

Summaries for Glioma Susceptibility 3

UniProtKB/Swiss-Prot : 72 Glioma 3: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.

MalaCards based summary : Glioma Susceptibility 3, also known as glioblastoma 3, is related to low grade glioma and glioma. An important gene associated with Glioma Susceptibility 3 is BRCA2 (BRCA2 DNA Repair Associated). Affiliated tissues include brain, and related phenotypes are astrocytoma and medulloblastoma

More information from OMIM: 613029 PS137800

Related Diseases for Glioma Susceptibility 3

Diseases in the Glioma Susceptibility 1 family:

Glioma Susceptibility 4 Glioma Susceptibility 2
Glioma Susceptibility 3 Glioma Susceptibility 5
Glioma Susceptibility 6 Glioma Susceptibility 7
Glioma Susceptibility 8 Glioma Susceptibility 9

Diseases related to Glioma Susceptibility 3 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 low grade glioma 9.7
2 glioma 9.7
3 glial tumor 9.7

Symptoms & Phenotypes for Glioma Susceptibility 3

Human phenotypes related to Glioma Susceptibility 3:

31
# Description HPO Frequency HPO Source Accession
1 astrocytoma 31 HP:0009592
2 medulloblastoma 31 HP:0002885
3 glioblastoma multiforme 31 HP:0012174

Symptoms via clinical synopsis from OMIM®:

57 (Updated 05-Apr-2021)
Neoplasia:
astrocytoma
medulloblastoma
glioblastoma
brain tumors, multiple types

Clinical features from OMIM®:

613029 (Updated 05-Apr-2021)

Drugs & Therapeutics for Glioma Susceptibility 3

Search Clinical Trials , NIH Clinical Center for Glioma Susceptibility 3

Genetic Tests for Glioma Susceptibility 3

Genetic tests related to Glioma Susceptibility 3:

# Genetic test Affiliating Genes
1 Glioma Susceptibility 3 29 BRCA2
2 Glioblastoma 3 29

Anatomical Context for Glioma Susceptibility 3

MalaCards organs/tissues related to Glioma Susceptibility 3:

40
Brain

Publications for Glioma Susceptibility 3

Articles related to Glioma Susceptibility 3:

(show all 18)
# Title Authors PMID Year
1
Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. 6 57
16825431 2007
2
Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour. 6 57
15689453 2005
3
Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. 6
14670928 2004
4
Early Mortality of Brain Cancer Patients and its Connection to Cytomegalovirus Reactivation During Radiochemotherapy. 61
32060103 2020
5
MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis. 61
30637843 2019
6
Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts. 61
28848341 2017
7
Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience. 61
26034629 2014
8
Taste and smell disturbances after brain irradiation: a dose-volume histogram analysis of a prospective observational study. 61
24890354 2014
9
Improved conspicuity and delineation of high-grade primary and metastatic brain tumors using "restriction spectrum imaging": quantitative comparison with high B-value DWI and ADC. 61
23139079 2013
10
The clinical features of spinal leptomeningeal dissemination from malignant gliomas. 61
21887390 2011
11
Salvage temozolomide for prior temozolomide responders. 61
16270316 2005
12
The transcription factor Gli3 regulates differentiation of fetal CD4- CD8- double-negative thymocytes. 61
15855276 2005
13
Do children with optic pathway tumors have an increased frequency of other central nervous system tumors? 61
12672283 2003
14
Ski is involved in transcriptional regulation by the repressor and full-length forms of Gli3. 61
12435627 2002
15
Brain tumors as second malignant neoplasms in patients with osteosarcoma treated with adjuvant and neoadjuvant chemotherapy: report of 2 cases. 61
10877524 2000
16
Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas. 61
9591593 1998
17
One-dimensional phosphorus-31 chemical shift imaging of human brain tumors. 61
7490188 1995
18
Toxicology studies on antineoplaston AS2-1 injections in cancer patients. 61
3743378 1986

Variations for Glioma Susceptibility 3

ClinVar genetic disease variations for Glioma Susceptibility 3:

6 (show top 50) (show all 58)
# Gene Name Type Significance ClinVarId dbSNP ID Position
1 BRCA2 NM_000059.4(BRCA2):c.145G>T (p.Glu49Ter) SNV Pathogenic 51129 rs80358435 GRCh37: 13:32893291-32893291
GRCh38: 13:32319154-32319154
2 BRCA2 NM_000059.4(BRCA2):c.92G>A (p.Trp31Ter) SNV Pathogenic 52808 rs397508045 GRCh37: 13:32893238-32893238
GRCh38: 13:32319101-32319101
3 BRCA2 NM_000059.4(BRCA2):c.100G>T (p.Glu34Ter) SNV Pathogenic 51041 rs80358391 GRCh37: 13:32893246-32893246
GRCh38: 13:32319109-32319109
4 BRCA2 NM_000059.4(BRCA2):c.3109C>T (p.Gln1037Ter) SNV Pathogenic 37819 rs80358557 GRCh37: 13:32911601-32911601
GRCh38: 13:32337464-32337464
5 BRCA2 NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) SNV Pathogenic 37936 rs80358721 GRCh37: 13:32913457-32913457
GRCh38: 13:32339320-32339320
6 BRCA2 NM_000059.4(BRCA2):c.6952C>T (p.Arg2318Ter) SNV Pathogenic 38076 rs80358920 GRCh37: 13:32920978-32920978
GRCh38: 13:32346841-32346841
7 BRCA2 NM_000059.4(BRCA2):c.9117G>A (p.Pro3039=) SNV Pathogenic 38215 rs28897756 GRCh37: 13:32954050-32954050
GRCh38: 13:32379913-32379913
8 BRCA2 NM_000059.3(BRCA2):c.1399A>T (p.Lys467Ter) SNV Pathogenic 51118 rs80358427 GRCh37: 13:32907014-32907014
GRCh38: 13:32332877-32332877
9 BRCA2 NM_000059.3(BRCA2):c.5791C>T (p.Gln1931Ter) SNV Pathogenic 51939 rs80358807 GRCh37: 13:32914283-32914283
GRCh38: 13:32340146-32340146
10 BRCA2 NM_000059.4(BRCA2):c.9117G>A (p.Pro3039=) SNV Pathogenic 38215 rs28897756 GRCh37: 13:32954050-32954050
GRCh38: 13:32379913-32379913
11 BRCA2 NM_000059.3(BRCA2):c.4243G>T (p.Glu1415Ter) SNV Pathogenic 37890 rs397507327 GRCh37: 13:32912735-32912735
GRCh38: 13:32338598-32338598
12 BRCA2 NM_000059.4(BRCA2):c.6656C>G (p.Ser2219Ter) SNV Pathogenic 52149 rs80358893 GRCh37: 13:32915148-32915148
GRCh38: 13:32341011-32341011
13 BRCA2 NM_000059.4(BRCA2):c.7879A>T (p.Ile2627Phe) SNV Pathogenic 52430 rs80359014 GRCh37: 13:32936733-32936733
GRCh38: 13:32362596-32362596
14 BRCA2 NM_000059.4(BRCA2):c.7988A>T (p.Glu2663Val) SNV Pathogenic 52462 rs80359031 GRCh37: 13:32937327-32937327
GRCh38: 13:32363190-32363190
15 BRCA2 NM_000059.4(BRCA2):c.8167G>C (p.Asp2723His) SNV Pathogenic 52515 rs41293511 GRCh37: 13:32937506-32937506
GRCh38: 13:32363369-32363369
16 BRCA2 NM_000059.4(BRCA2):c.8488-1G>A SNV Pathogenic 38164 rs397507404 GRCh37: 13:32945092-32945092
GRCh38: 13:32370955-32370955
17 BRCA2 NM_000059.4(BRCA2):c.9294C>G (p.Tyr3098Ter) SNV Pathogenic 38229 rs80359200 GRCh37: 13:32968863-32968863
GRCh38: 13:32394726-32394726
18 BRCA2 NM_000059.4(BRCA2):c.9382C>T (p.Arg3128Ter) SNV Pathogenic 52826 rs80359212 GRCh37: 13:32968951-32968951
GRCh38: 13:32394814-32394814
19 BRCA2 NM_000059.4(BRCA2):c.5857G>T (p.Glu1953Ter) SNV Pathogenic 51952 rs80358814 GRCh37: 13:32914349-32914349
GRCh38: 13:32340212-32340212
20 BRCA2 NM_000059.4(BRCA2):c.5682C>G (p.Tyr1894Ter) SNV Pathogenic 37989 rs41293497 GRCh37: 13:32914174-32914174
GRCh38: 13:32340037-32340037
21 BRCA2 NM_000059.4(BRCA2):c.7480C>T (p.Arg2494Ter) SNV Pathogenic 38099 rs80358972 GRCh37: 13:32930609-32930609
GRCh38: 13:32356472-32356472
22 BRCA2 NM_000059.4(BRCA2):c.658_659del Deletion risk factor 9342 rs80359604 GRCh37: 13:32903605-32903606
GRCh38: 13:32329468-32329469
23 BRCA2 NM_000059.4(BRCA2):c.5645C>G (p.Ser1882Ter) SNV risk factor 9346 rs80358785 GRCh37: 13:32914137-32914137
GRCh38: 13:32340000-32340000
24 BRCA2 NM_000059.3(BRCA2):c.7051G>A (p.Ala2351Thr) SNV Uncertain significance 52256 rs80358930 GRCh37: 13:32929041-32929041
GRCh38: 13:32354904-32354904
25 BRCA2 NM_000059.3(BRCA2):c.3808G>A (p.Val1270Ile) SNV Uncertain significance 231069 rs876658938 GRCh37: 13:32912300-32912300
GRCh38: 13:32338163-32338163
26 BRCA2 NM_000059.3(BRCA2):c.6148G>A (p.Val2050Ile) SNV Uncertain significance 52019 rs80358854 GRCh37: 13:32914640-32914640
GRCh38: 13:32340503-32340503
27 BRCA2 NM_000059.3(BRCA2):c.6818G>A (p.Arg2273Lys) SNV Uncertain significance 142005 rs587782174 GRCh37: 13:32915310-32915310
GRCh38: 13:32341173-32341173
28 BRCA2 NM_000059.3(BRCA2):c.8817G>C (p.Lys2939Asn) SNV Uncertain significance 38187 rs397507414 GRCh37: 13:32953516-32953516
GRCh38: 13:32379379-32379379
29 BRCA2 NM_000059.4(BRCA2):c.3835A>G (p.Asn1279Asp) SNV Uncertain significance 51534 rs80358626 GRCh37: 13:32912327-32912327
GRCh38: 13:32338190-32338190
30 BRCA2 NM_000059.3(BRCA2):c.7625C>T (p.Thr2542Met) SNV Uncertain significance 96854 rs80358989 GRCh37: 13:32931886-32931886
GRCh38: 13:32357749-32357749
31 BRCA2 NM_000059.3(BRCA2):c.1433C>A (p.Thr478Lys) SNV Uncertain significance 96764 rs431825282 GRCh37: 13:32907048-32907048
GRCh38: 13:32332911-32332911
32 BRCA2 NM_000059.3(BRCA2):c.2122T>A (p.Ser708Thr) SNV Uncertain significance 51246 rs80358488 GRCh37: 13:32910614-32910614
GRCh38: 13:32336477-32336477
33 BRCA2 NM_000059.4(BRCA2):c.2405A>G (p.Asn802Ser) SNV Uncertain significance 234566 rs876661089 GRCh37: 13:32910897-32910897
GRCh38: 13:32336760-32336760
34 BRCA2 NM_000059.3(BRCA2):c.2908G>A (p.Asp970Asn) SNV Uncertain significance 37806 rs397507295 GRCh37: 13:32911400-32911400
GRCh38: 13:32337263-32337263
35 BRCA2 NM_000059.3(BRCA2):c.4478A>G (p.Glu1493Gly) SNV Uncertain significance 126045 rs80358679 GRCh37: 13:32912970-32912970
GRCh38: 13:32338833-32338833
36 BRCA2 NM_000059.3(BRCA2):c.4535G>A (p.Arg1512His) SNV Uncertain significance 51661 rs80358685 GRCh37: 13:32913027-32913027
GRCh38: 13:32338890-32338890
37 BRCA2 NM_000059.3(BRCA2):c.4825A>G (p.Thr1609Ala) SNV Uncertain significance 231512 rs876659201 GRCh37: 13:32913317-32913317
GRCh38: 13:32339180-32339180
38 BRCA2 NM_000059.3(BRCA2):c.5747A>G (p.His1916Arg) SNV Uncertain significance 96828 rs431825334 GRCh37: 13:32914239-32914239
GRCh38: 13:32340102-32340102
39 BRCA2 NM_000059.3(BRCA2):c.5962G>A (p.Val1988Ile) SNV Uncertain significance 91430 rs28897739 GRCh37: 13:32914454-32914454
GRCh38: 13:32340317-32340317
40 BRCA2 NM_000059.3(BRCA2):c.5986G>T (p.Ala1996Ser) SNV Uncertain significance 38012 rs80358833 GRCh37: 13:32914478-32914478
GRCh38: 13:32340341-32340341
41 BRCA2 NM_000059.3(BRCA2):c.6626T>C (p.Ile2209Thr) SNV Uncertain significance 96840 rs431825344 GRCh37: 13:32915118-32915118
GRCh38: 13:32340981-32340981
42 BRCA2 NM_000059.3(BRCA2):c.6706G>A (p.Glu2236Lys) SNV Uncertain significance 52165 rs41293503 GRCh37: 13:32915198-32915198
GRCh38: 13:32341061-32341061
43 BRCA2 NM_000059.3(BRCA2):c.1282C>A (p.Leu428Ile) SNV Uncertain significance 187437 rs547590567 GRCh37: 13:32906897-32906897
GRCh38: 13:32332760-32332760
44 BRCA2 NM_000059.3(BRCA2):c.6877T>C (p.Phe2293Leu) SNV Uncertain significance 52216 rs80358912 GRCh37: 13:32918730-32918730
GRCh38: 13:32344593-32344593
45 BRCA2 NM_000059.3(BRCA2):c.7051G>A (p.Ala2351Thr) SNV Uncertain significance 52256 rs80358930 GRCh37: 13:32929041-32929041
GRCh38: 13:32354904-32354904
46 BRCA2 NM_000059.3(BRCA2):c.7447A>G (p.Ser2483Gly) SNV Uncertain significance 52334 rs80358966 GRCh37: 13:32930576-32930576
GRCh38: 13:32356439-32356439
47 BRCA2 NM_000059.3(BRCA2):c.7628A>G (p.Tyr2543Cys) SNV Uncertain significance 96855 rs431825354 GRCh37: 13:32931889-32931889
GRCh38: 13:32357752-32357752
48 BRCA2 NM_000059.3(BRCA2):c.7781A>G (p.Lys2594Arg) SNV Uncertain significance 234138 rs876660874 GRCh37: 13:32932042-32932042
GRCh38: 13:32357905-32357905
49 BRCA2 NM_000059.3(BRCA2):c.8007A>T (p.Arg2669Ser) SNV Uncertain significance 183981 rs143999963 GRCh37: 13:32937346-32937346
GRCh38: 13:32363209-32363209
50 BRCA2 NM_000059.3(BRCA2):c.9218A>G (p.Asp3073Gly) SNV Uncertain significance 52779 rs80359186 GRCh37: 13:32954244-32954244
GRCh38: 13:32380107-32380107

Cosmic variations for Glioma Susceptibility 3:

9 (show top 50) (show all 19971)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM85192834 ZW10 central nervous system,NS,glioma,astrocytoma Grade IV c.2140C>T p.P714S 11:113736699-113736699 3
2 COSM86922763 ZSWIM4 central nervous system,NS,glioma,astrocytoma Grade IV c.266C>T p.P89L 19:13799832-13799832 3
3 COSM88263742 ZRSR2 central nervous system,NS,glioma,astrocytoma Grade IV c.340C>T p.Q114* 23:15804138-15804138 3
4 COSM88261602 ZRSR2 central nervous system,NS,glioma,astrocytoma Grade IV c.961C>T p.P321S 23:15822754-15822754 3
5 COSM88263021 ZRSR2 central nervous system,NS,glioma,astrocytoma Grade IV c.260G>A p.R87K 23:15803744-15803744 3
6 COSM88261596 ZRSR2 central nervous system,NS,glioma,astrocytoma Grade IV c.271G>A p.E91K 23:15803755-15803755 3
7 COSM88262556 ZRSR2 central nervous system,NS,glioma,oligodendroglioma c.220G>A p.E74K 23:15803704-15803704 3
8 COSM87830624 ZPLD1 central nervous system,NS,glioma,astrocytoma Grade IV c.393A>T p.G131= 3:102456210-102456210 3
9 COSM119316158 ZPLD1 central nervous system,NS,glioma,astrocytoma Grade IV c.345A>T p.G115= 3:102456210-102456210 3
10 COSM116178212 ZPLD1 central nervous system,NS,glioma,astrocytoma Grade IV c.345A>T p.G115= 3:102456210-102456210 3
11 COSM106156998 ZNF697 central nervous system,NS,glioma,astrocytoma Grade IV c.1550G>A p.G517D 1:119622793-119622793 3
12 COSM93171584 ZNF687 central nervous system,NS,glioma,astrocytoma Grade IV c.3651C>T p.T1217= 1:151291146-151291146 3
13 COSM93173649 ZNF687 central nervous system,NS,glioma,astrocytoma Grade IV c.2044T>A p.C682S 1:151288335-151288335 3
14 COSM93173639 ZNF687 central nervous system,NS,glioma,astrocytoma Grade IV c.2043G>C p.Q681H 1:151288334-151288334 3
15 COSM92762364 ZNF507 central nervous system,NS,glioma,astrocytoma Grade IV c.1517G>C p.R506T 19:32354347-32354347 3
16 COSM91851905 ZNF507 central nervous system,NS,glioma,astrocytoma Grade IV c.1517G>C p.R506T 19:32354347-32354347 3
17 COSM130988554 ZNF507 central nervous system,NS,glioma,astrocytoma Grade IV c.1517G>C p.R506T 19:32354347-32354347 3
18 COSM141250987 ZNF473 central nervous system,NS,glioma,astrocytoma Grade IV c.42C>T p.D14= 19:50039193-50039193 3
19 COSM84172269 ZNF473 central nervous system,NS,glioma,astrocytoma Grade IV c.42C>T p.D14= 19:50039193-50039193 3
20 COSM141790125 ZNF473 central nervous system,NS,glioma,astrocytoma Grade IV c.42C>T p.D14= 19:50039193-50039193 3
21 COSM99924035 ZNF473 central nervous system,NS,glioma,astrocytoma Grade IV c.42C>T p.D14= 19:50039193-50039193 3
22 COSM111538647 ZNF473 central nervous system,NS,glioma,astrocytoma Grade IV c.6C>T p.D2= 19:50039193-50039193 3
23 COSM84507966 ZNF276 central nervous system,NS,glioma,astrocytoma Grade IV c.*664G>A p.? 16:89738910-89738910 3
24 COSM102909520 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2116G>A p.D706N 20:47246116-47246116 3
25 COSM116582422 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2176G>A p.D726N 20:47246116-47246116 3
26 COSM92864918 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2102T>G p.V701G 20:47246130-47246130 3
27 COSM111370233 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2116G>A p.D706N 20:47246116-47246116 3
28 COSM91410147 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2116G>A p.D706N 20:47246116-47246116 3
29 COSM97055096 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.1913T>G p.V638G 20:47246130-47246130 3
30 COSM112970642 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2176G>A p.D726N 20:47246116-47246116 3
31 COSM92871777 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2116G>A p.D706N 20:47246116-47246116 3
32 COSM85475347 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2102T>G p.V701G 20:47246130-47246130 3
33 COSM143801239 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2041G>A p.D681N 20:47246116-47246116 3
34 COSM114834078 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2087T>G p.V696G 20:47246130-47246130 3
35 COSM114839982 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2101G>A p.D701N 20:47246116-47246116 3
36 COSM91535436 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2176G>A p.D726N 20:47246116-47246116 3
37 COSM91528627 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2162T>G p.V721G 20:47246130-47246130 3
38 COSM133275210 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.1960G>A p.D654N 20:47246116-47246116 3
39 COSM143618110 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2116G>A p.D706N 20:47246116-47246116 3
40 COSM111362863 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2102T>G p.V701G 20:47246130-47246130 3
41 COSM91401933 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2102T>G p.V701G 20:47246130-47246130 3
42 COSM130874736 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2197G>A p.D733N 20:47246116-47246116 3
43 COSM116576154 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2162T>G p.V721G 20:47246130-47246130 3
44 COSM143862983 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2101G>A p.D701N 20:47246116-47246116 3
45 COSM143796197 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2027T>G p.V676G 20:47246130-47246130 3
46 COSM102902986 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2102T>G p.V701G 20:47246130-47246130 3
47 COSM133265728 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.1946T>G p.V649G 20:47246130-47246130 3
48 COSM85483642 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2116G>A p.D706N 20:47246116-47246116 3
49 COSM112964306 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2162T>G p.V721G 20:47246130-47246130 3
50 COSM143856741 ZMYND8 central nervous system,NS,glioma,astrocytoma Grade IV c.2087T>G p.V696G 20:47246130-47246130 3

Expression for Glioma Susceptibility 3

Search GEO for disease gene expression data for Glioma Susceptibility 3.

Pathways for Glioma Susceptibility 3

GO Terms for Glioma Susceptibility 3

Sources for Glioma Susceptibility 3

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....